CompanyScope

Insmed Inc. income statement & cash flow

Ticker INSM · SEC CIK 1104506 · Latest fiscal year ended Dec 31, 2025

In the fiscal year ended Dec 31, 2025, Insmed Inc. reported net income of −$1.28B on revenue of $606.42M. Operating cash flow was −$935.01M and capital expenditures were $32.56M, leaving −$967.58M of free cash flow (operating cash flow minus capital expenditures).

−$2B−$1B−$500M$0Dec 2016: −$176.27MDec 2017: −$192.65MDec 2018: −$324.28MDec 2019: −$254.34MDec 2020: −$294.09MDec 2021: −$434.65MDec 2022: −$481.53MDec 2023: −$749.57MDec 2024: −$913.77MDec 2025: −$1.28BDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Insmed Inc. net income by fiscal year, USD. Hover a bar for the exact figure.

Income statement and cash flow summary

Fiscal year endedDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue (USD)$0$0$9.84M$136.47M$164.41M$188.46M$245.36M$305.21M$363.71M$606.42M
Gross profit (USD)—$0$7.41M$112.25M——————
Operating income (USD)−$173.40M−$188.92M−$307.34M−$235.25M−$265.23M−$375.09M−$457.32M−$709.63M−$878.25M−$1.25B
Net income (USD)−$176.27M−$192.65M−$324.28M−$254.34M−$294.09M−$434.65M−$481.53M−$749.57M−$913.77M−$1.28B
Diluted EPS (USD per share)———−$3.01−$3.01−$3.88−$3.91−$5.34−$5.57−$6.42
Operating cash flow (USD)−$146.71M−$159.62M−$257.98M−$250.65M−$219.35M−$363.30M−$400.44M−$536.25M−$683.88M−$935.01M
Capital expenditures (USD)$4.20M$3.00M$13.09M$42.27M$6.24M$7.29M$9.88M$13.29M$21.92M$32.56M
Reported in10-K 201910-K 202010-K 202110-K 202210-K 202310-K 202410-K 202510-K 202610-K 202610-K 2026

Columns are fiscal years, labeled by the month the year ended; scroll sideways on small screens. — means the company did not report the figure under the XBRL concepts we track.

Margins

Each figure divided by revenue for the same fiscal year.

Fiscal year endedGross marginOperating marginNet margin
Dec 2025—-205.6%-210.5%
Dec 2024—-241.5%-251.2%
Dec 2023—-232.5%-245.6%
Dec 2022—-186.4%-196.3%
Dec 2021—-199.0%-230.6%
−$1B−$750M−$500M−$250M$0Dec 2016: −$146.71MDec 2017: −$159.62MDec 2018: −$257.98MDec 2019: −$250.65MDec 2020: −$219.35MDec 2021: −$363.30MDec 2022: −$400.44MDec 2023: −$536.25MDec 2024: −$683.88MDec 2025: −$935.01MDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Insmed Inc. operating cash flow by fiscal year, USD. Hover a bar for the exact figure.

Source: SEC EDGAR XBRL company facts for CIK 1104506 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.